Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169.
N Engl J Med. 2023.
PMID: 38055253
Clinical Trial.
tRNAGlyGCC-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression.
Panoutsopoulou K, Dreyer T, Dorn J, Obermayr E, Mahner S, Gorp TV, Braicu I, Zeillinger R, Magdolen V, Avgeris M, Scorilas A.
Panoutsopoulou K, et al. Among authors: gorp tv.
Cancers (Basel). 2021 Dec 22;14(1):24. doi: 10.3390/cancers14010024.
Cancers (Basel). 2021.
PMID: 35008188
Free PMC article.
Item in Clipboard
The use of lymph vessel markers to predict endometrial cancer outcome.
Vandenput I, Vanhove T, Calster BV, Gorp TV, Moerman P, Verbist G, Vergote I, Amant F.
Vandenput I, et al. Among authors: gorp tv.
Int J Gynecol Cancer. 2010 Apr;20(3):363-7. doi: 10.1111/IGC.0b013e3181d4a0b9.
Int J Gynecol Cancer. 2010.
PMID: 20375798
Item in Clipboard
Cite
Cite